Cargando…
Personalized Drug Analysis in B Cell Chronic Lymphocytic Leukemia Patients
BACKGROUND: B cell chronic lymphocytic leukemia (B-CLL) is the most common adult leukemia in the Western world. Although therapeutic advances have notably improved the outcome for many patients, B-CLL remains an incurable disease. The purpose of this study was to search for therapeutic drugs based o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432060/ https://www.ncbi.nlm.nih.gov/pubmed/28477439 http://dx.doi.org/10.12659/MSM.900738 |